###begin article-title 0
###xml 48 53 <span type="species:ncbi:9606">Women</span>
BRCA1 and BRCA2 Germline Mutations in Malaysian Women with Early-Onset Breast Cancer without a Family History
###end article-title 0
###begin p 1
Conceived and designed the experiments: ST GT. Performed the experiments: GT PK DL SL SS. Analyzed the data: SL. Contributed reagents/materials/analysis tools: NM SY CY. Wrote the paper: ST SL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 115 120 <span type="species:ncbi:9606">women</span>
In Asia, breast cancer is characterised by an early age of onset: In Malaysia, approximately 50% of cases occur in women under the age of 50 years. A proportion of these cases may be attributable, at least in part, to genetic components, but to date, the contribution of genetic components to breast cancer in many of Malaysia's ethnic groups has not been well-characterised.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA</italic>
###xml 322 327 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 332 337 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Given that hereditary breast carcinoma is primarily due to germline mutations in one of two breast cancer susceptibility genes, BRCA1 and BRCA2, we have characterised the spectrum of BRCA mutations in a cohort of 37 individuals with early-onset disease (</=40 years) and no reported family history. Mutational analysis of BRCA1 and BRCA2 was conducted by full sequencing of all exons and intron-exon junctions.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Here, we report a total of 14 BRCA1 and 17 BRCA2 sequence alterations, of which eight are novel (3 BRCA1 and 5 BRCA2). One deleterious BRCA1 mutation and 2 deleterious BRCA2 mutations, all of which are novel mutations, were identified in 3 of 37 individuals. This represents a prevalence of 2.7% and 5.4% respectively, which is consistent with other studies in other Asian ethnic groups (4-9%).
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Ferlay1">[1]</xref>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Ferlay1">[1]</xref>
###xml 290 293 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Parkin1">[2]</xref>
Carcinoma of the breast is the most prevalent female malignancy worldwide [1]. However, there is considerable geographical variation in disease rates whereby the highest age-standardised incidence rates (ASR) are found in developed regions in the West such as North America and Europe [1], [2]. Incidence rates in developing areas and countries of the Far East, albeit on the rise, are substantially lower.
###end p 9
###begin p 10
###xml 183 186 183 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Lim1">[3]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Parkin1">[2]</xref>
###xml 637 640 637 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Ferlay1">[1]</xref>
###xml 712 715 712 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Porter1">[4]</xref>
###xml 1163 1166 1163 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Claus1">[5]</xref>
###xml 1167 1170 1167 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Fitzgerald1">[7]</xref>
###xml 146 151 <span type="species:ncbi:9606">women</span>
###xml 484 489 <span type="species:ncbi:9606">women</span>
In Malaysia, breast cancer constituted 31% of all newly diagnosed female cancer cases in 2003, making it the most common cancer amongst Malaysian women across all major ethnic groups [3]. The overall incidence rate in 2003 (ASR of 46.2 per 100,000) is comparable to that of Singapore and the Philippines, but are relatively higher than those reported in China, Japan, India and Thailand [2]. It is also noteworthy that approximately half of the cases reported in Malaysia occurred in women under the age of 50 years. The apparent lower mean age of onset compared to the Western population has also been reported in other Asian countries [1]. One possible explanation is the "Westernization" of these populations [4], i.e. delayed childbearing, lower parity, reduced breast-feeding, decreased exercise and dietary changes, has led to a 'cohort effect' where the younger cohort have increased breast cancer risk compared to their mothers and grandmothers, thus giving rise to an apparent lower mean age of onset. However, given that an individual with breast cancer is more likely to carry a susceptibility gene mutation the younger she is at the time of diagnosis [5]-[7], an alternative possibility is that the allelic frequency of high penetrance genes in the Asian population may be higher than that in Caucasian populations.
###end p 10
###begin p 11
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Miki1">[8]</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Wooster2">[10]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Ford1">[11]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Wooster3">[14]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Narod1">[15]</xref>
Hereditary breast carcinomas are predominantly a consequence of loss-of-function germline mutations in one of two major breast cancer susceptibility genes, BRCA1 and BRCA2[8]-[10]. Epidemiological studies suggest that deleterious mutations in either of these genes confer a significant increase in lifetime risk of developing breast and, to a lesser extent, ovarian cancers [11]-[14]. It is argued that this estimated risk is nonetheless imprecise and may be further modified by other genetic and non-genetic factors [15].
###end p 11
###begin p 12
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA</italic>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA</italic>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Leide1">[16]</xref>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Leide1">[16]</xref>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Zhi1">[23]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Leide1">[16]</xref>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA</italic>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Balraj1">[24]</xref>
###xml 1031 1036 1031 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1041 1046 1041 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 152 157 <span type="species:ncbi:9606">women</span>
###xml 513 518 <span type="species:ncbi:9606">women</span>
###xml 1108 1113 <span type="species:ncbi:9606">women</span>
Our current understanding of BRCA mutations and their contribution to hereditary breast cancer has arisen primarily from studies conducted in Caucasian women. A number of studies which have been carried out in several Asian countries, however, indicate that BRCA mutations are equally prevalent or may possibly be higher within the Asian population [16]. The majority of studies to date, particularly those in South East Asia, have focused primarily on BRCA1, with few comprehensive reports on the BRCA2 gene. In women with early-onset breast carcinoma unselected for family history, the prevalence of BRCA1 mutations is estimated to be between four and nine percent [16]-[23]. Founder mutations that are unique to Asians have also been described [16]. Despite this emerging knowledge, little is known about the spectrum and frequency of BRCA mutations and their involvement in breast cancer incidence within the ethnically diverse Malaysian population of Malays, Chinese & Indians [24]. This report describes sequence variants of BRCA1 and BRCA2 that were identified in a hospital-based cohort of Malaysian women with early onset breast cancer (</=40 years) with no reported family history of breast and/or ovarian cancers.
###end p 12
###begin title 13
Results
###end title 13
###begin p 14
###xml 357 360 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Lim1">[3]</xref>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
The Malaysian population is characterised by three major ethnic groups: the Malays (62%), Chinese (27%) and Indians (9%). Of the 3,738 new cases reported in 2003, 43.6% of patients were Chinese, while 39.7% were Malay and 11% were of Indian origin. Notably, the age-standardised incidence is higher among the Chinese and Indians in comparison to the Malays [3].
###end p 14
###begin p 15
###xml 1506 1510 1506 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Sim1">[25]</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 659 664 <span type="species:ncbi:9606">women</span>
###xml 1046 1051 <span type="species:ncbi:9606">women</span>
###xml 1375 1380 <span type="species:ncbi:9606">women</span>
###xml 1612 1617 <span type="species:ncbi:9606">women</span>
Patients for this study were recruited from one major breast cancer referral hospital in Malaysia, the University Malaya Medical Centre (UMMC), Kuala Lumpur. Due to its demographics, a larger proportion of patients i.e. 59.4% treated at this hospital were ethnically Chinese, compared to 25.8% Malays and 13.4% Indians. However, comparisons between the hospital and population data set show that collectively, breast cancer cases managed by UMMC over a ten-year period from 1996-2005 essentially mirror those that were reported to the national registry in 2003. Firstly, approximately 50% of cases in the population and those seen at the hospital occurred in women under the age of 50 years, 15% of whom were 40 years and below. Secondly, the most prevalent age group in both the population and hospital-based series was 40-49 years, whereby an average of 34% of all cases lies within this age bracket. Thirdly, discernable differences that are observed between the three ethnic groups are found in both the population and hospital data sets. In women below the age of 50 years, breast cancer incidence increased with age in all three ethnic groups. However, after the age of 50, incidence decreased in the Chinese and Malays but continued to rise within the Indian sub-population. A similar trend has been noted in an extensive study of trends of breast cancer incidence in women in Singapore, a country that is characterised by the same major ethnic groups, albeit in significantly different proportions [25]. Finally, it is clear that in both the population- and hospital-based series, disease onset in Malay women occur at a younger age in comparison to the Chinese and Indians. Taken together, this suggests that the hospital-based cohort is largely reflective of breast cancer cases within the Malaysian population.
###end p 15
###begin p 16
###xml 436 441 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 449 454 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 512 520 510 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002024-t001">Tables 1</xref>
###xml 523 524 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002024-t002">2</xref>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
A total of 37 proband patients diagnosed with early-onset breast cancer (</=40 years) with a mean age of 33.7 years and no known family history of the disease were selected for this study. The ethnicity of this study group reflected the ethnicity of the hospital-based sample collection i.e. 21 Chinese (56.8%), 11 Malays (29.7%), 4 Indians (10.8%) and 1 individual of mixed race (2.7%). Within this cohort, we identified a total of 14 BRCA1 and 17 BRCA2 sequence variants, of which ten are novel (summarised in Tables 1 & 2).
###end p 16
###begin title 17
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
Sequence variants identified in the BRCA1 gene.
###end title 17
###begin p 18
MS, missense; Syn, synonymous; FS, frameshift; VUS, variant of uncertain significance; BIC, Breast Information Core
###end p 18
###begin title 19
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Sequence variants identified in the BRCA2 gene.
###end title 19
###begin p 20
These sequence alterations are likely to be polymorphisms. They have been classified as benign as allelic frequency data from population studies are not currently available. MS, missense; Syn, synonymous; FS, frameshift; VUS, variant of uncertain significance; BIC, Breast Information Core
###end p 20
###begin title 21
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
BRCA1 Sequence Variants
###end title 21
###begin p 22
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 107 114 107 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002024-t001">Table 1</xref>
###xml 303 310 <span type="species:ncbi:9606">patient</span>
Fourteen BRCA1 sequence variants, including three novel changes, were identified in this study population (Table 1). Only one clearly disease-associated mutation was found in this cohort. The splice site mutation (IVS3+2delT), which occurs within the proximal splice site of exon 3, was detected in one patient of Chinese descent.
###end p 22
###begin p 23
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Abkevich1">[27]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Suter1">[26]</xref>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Two BRCA1 missense variants of uncertain significance were identified in two out of 37 proband patients (5.4%). One variant at position 2405 (A>T) in exon 11 that led to a substitution of Ser for Arg residue at position 762 (R762S) was detected in an individual of Malay descent. Although its clinical significance is presently unknown, this substitution of this invariant Arg [27], which occurs outside any known functional domain, is unlikely to contribute to increased risk to breast cancer because it has been reported to occur in a cohort of cancer-free individuals [26].
###end p 23
###begin p 24
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Tang1">[18]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Suter1">[26]</xref>
###xml 79 86 <span type="species:ncbi:9606">patient</span>
The second BRCA1 variant of uncertain significance was identified in a Chinese patient. It involved an alteration at position 2685 (T>C) that resulted in a Tyr to His substitution at codon 856 (Y856H) in exon 11. This variant has been reported previously occurring at similar frequencies in breast cancer and cancer-free individuals of Chinese descent in Hong Kong [18] and Shanghai [26], suggesting that this variant is neutral or of little pathological significance.
###end p 24
###begin p 25
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 79 86 79 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002024-t001">Table 1</xref>
###xml 1346 1350 1346 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Tang1">[18]</xref>
###xml 1352 1356 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Saxena1">[22]</xref>
###xml 1391 1394 1391 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Miki1">[8]</xref>
###xml 1396 1400 1396 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Durocher1">[28]</xref>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 739 747 <span type="species:ncbi:9606">patients</span>
###xml 888 895 <span type="species:ncbi:9606">patient</span>
###xml 1166 1173 <span type="species:ncbi:9606">patient</span>
Eleven additional BRCA1 sequence variants were identified in this study group (Table 1). These include two novel changes in exon 11 that were detected in two Chinese patients. These variants are considered benign and may be polymorphisms as the single base alterations do not lead to amino acid substitutions (L625L and P977P) and are unlikely to be potential splice site variants. A further nine variants that were identified have been reported previously in BIC and are classified as neutral polymorphisms. Two alterations, a synonymous alteration in exon 3 (K38K) and a missense substitution in exon 11 leading to an Asp for Asn substitution at codon 693 (D693N), are rare and were only identified once each (1/37, 2.7%) in two Chinese patients. In contrast, seven other single nucleotide polymorphisms were found in 75.7% (28/37) of individuals across all three ethnic groups in this patient population. These correspond to three silent substitutions in exon 11 (S694S and L771L) and exon 13 (S1436S), and four missense changes in exon 11 (P871L, E1038G, K1183R) and exon 16 (S1613G). This block of seven common polymorphisms always occurred concurrently i.e. a patient that carries one variant was always found to carry the other six variants. Similarly, five of these polymorphic sites in exon 11 have been noted to co-occur in other Asian [18], [22], as well as Caucasian populations [8], [28].
###end p 25
###begin title 26
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
BRCA2 Sequence Variants
###end title 26
###begin p 27
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 132 139 132 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002024-t002">Table 2</xref>
###xml 112 119 <span type="species:ncbi:9606">patient</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
A total of 17 BRCA2 sequence variants, five of which have not been previously reported, were identified in this patient population (Table 2). These include two distinct frameshift mutations that are predicted to encode truncated proteins and three missense variants of uncertain clinical significance. The two deleterious frameshift mutations were detected in two patients (5.4%) of Chinese descent. The first is a 2-bp deletion at nucleotide 2862 (2862 delCT) while the second involves the deletion of adenosine at position 6901 (6901 delA). These two alterations are predicted to result in premature STOP codons at positions 879 (STOP 879) and 2228 (STOP 2228), respectively.
###end p 27
###begin p 28
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 124 131 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002024-t002">Table 2</xref>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1014 1015 1014 1015 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 1022 1023 1022 1023 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</underline>
###xml 1033 1034 1033 1034 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</underline>
###xml 1038 1039 1038 1039 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 1047 1051 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Ng1">[30]</xref>
###xml 1286 1290 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Suter1">[26]</xref>
###xml 523 526 <span type="species:ncbi:9615">dog</span>
###xml 528 533 <span type="species:ncbi:10090">mouse</span>
###xml 538 543 <span type="species:ncbi:9031">chick</span>
###xml 785 793 <span type="species:ncbi:9606">patients</span>
###xml 1207 1212 <span type="species:ncbi:9606">women</span>
###xml 1332 1337 <span type="species:ncbi:9606">women</span>
The three BRCA2 variants of uncertain significance identified in this study correspond to substitutions in exons 10 and 11 (Table 2) and none are likely to be clinically relevant. One is a novel variant which encodes a Thr to Pro substitution at codon 1723. This variant was detected in an index case who also carries the novel BRCA1 R762S variant of uncertain significance. Based on multiple sequence alignment analysis, this Thr residue is not highly evolutionarily conserved, with alternative amino acids being found in dog, mouse and chick. Furthermore, the pairwise GMS of 38 for a Thr to Pro change is relatively low. Taken together, this variant is not likely to be disease causative. Two other missense variants of uncertain significance, C315S and M1149V were detected in two patients of Chinese and Malay descent, respectively. These two variants have been reported in BIC, primarily in individuals of Asian origin. Based on multiple sequence alignment analysis, Grantham score (GMS = 112) and the SIFT (Sorting Intolerant From Tolerant [30]) prediction programme, the C315S missense mutation is not likely to affect protein function. In addition, the observations of a study conducted on Chinese women from Shanghai also argue against the deleterious nature of this mutation [26]. This sequence variant was identified in women with benign breast disease as well as individuals within the control cohort. Likewise, the M1149V variant is predicted to be a neutral alteration that has little clinical significance. This is because a Met to Val alteration is a conservative substitution, as indicated by a relatively low Grantham chemical difference score of 21, and occurs at a residue that is not evolutionarily conserved.
###end p 28
###begin p 29
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002024-t002">Table 2</xref>
###xml 190 197 <span type="species:ncbi:9606">patient</span>
###xml 344 352 <span type="species:ncbi:9606">patients</span>
In addition to the two novel frameshift mutations and an unreported variant of uncertain significance, we identified three distinct synonymous mutations, of which two are novel, within this patient population (Table 2). These single nucleotide changes in exons 10 (E425E), 11 (T1526T) and 17 (L2647L) were identified once (1/37, 2.7%) in three patients and are unlikely to be potential splice site variants. Although these are most likely polymorphisms, they have been classified as clinically benign synonymous sequence variants because allelic frequency data from population studies are currently not available.
###end p 29
###begin p 30
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
###xml 669 677 <span type="species:ncbi:9606">patients</span>
###xml 970 978 <span type="species:ncbi:9606">patients</span>
###xml 1037 1045 <span type="species:ncbi:9606">patients</span>
Nine previously reported common BRCA2 polymorphisms were also identified in this study group. These polymorphisms corresponded to sequence alterations in exons 10, 11 and 14. Four sequence variants involved changes that resulted in amino acid substitutions (N289H, H372N, N991D and G1771D) while five were synonymous changes (S455S, H743H, K1132K, V1269V and S2414S) that did not affect the protein sequence of BRCA2. These nine polymorphic sites were found to occur at varying frequencies. One variant, G1771D, was identified in one of 37 patients (2.7%). Four of these, namely N289H and S455S in exon 10 and H743H and N991D in exon 11, occurred concurrently in three patients (3/37, 8.1%). The V1269V alteration in exon 11 was detected in 21.6% (8/37) of the study group while the three remaining polymorphisms, H372N (exon 10), K1132K (exon 11) and S2414S (exon 14), occurred at relatively high frequencies. They were detected in more than 50% of the cohort, with 28 patients carrying at least one of the three variants. Of these, 12 patients (12/28, 42.9%) were found to carry all three polymorphisms.
###end p 30
###begin title 31
Conclusion
###end title 31
###begin p 32
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 243 248 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
Mutational analysis by direct sequencing of the entire coding region of the BRCA1 and BRCA2 genes on 37 breast cancer patients aged 40 years and under, with no reported family history of breast and/or ovarian cancers, identified a total of 14 BRCA1 and 17 BRCA2 sequence variants. These include ten novel mutations (4 BRCA1 and 6 BRCA2) that have not been previously reported. One pathogenic BRCA1 mutation and two novel pathogenic BRCA2 mutations were detected in two of 37 index cases. This represents a prevalence of 2.7% and 5.4% respectively.
###end p 32
###begin p 33
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002024-Balraj1">[24]</xref>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA</italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
To date, only one other mutational analysis has been conducted on Malaysian breast cancer patients [24]. This study focused exclusively on the BRCA1 gene. Clearly, there remain gaps in our understanding of how germline mutations in BRCA genes contribute towards breast cancer incidence in Malaysia, but given the relatively low yield of deleterious mutations in BRCA1 and BRCA2 despite a thorough examination of both genes, it might be concluded that germline mutations at these sites are unlikely to contribute to the observed lower age of onset of breast cancer compared to Western series.
###end p 33
###begin title 34
Materials and Methods
###end title 34
###begin p 35
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
A total of 619 pathologically confirmed breast cancer patients were recruited from the University Malaya Medical Centre (UMMC) in Kuala Lumpur, Malaysia between January 2003 and December 2006. Family histories were obtained by interviewing patients. From these, 37 individuals with early onset disease (</=40 years) without any first and/or second degree relatives affected with breast and/or ovarian cancers were selected for this study cohort. Prior approval for this study was obtained from the University Malaya Medical Centre ethics committee, and written informed consent was obtained from all participating subjects.
###end p 35
###begin p 36
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
DNA from peripheral blood was extracted using standard techniques and the entire coding sequence of BRCA1 and BRCA2 and splice sites (20 bp upstream and 10 bp downstream) were analysed for sequence variants by PCR and direct nucleotide sequencing. Samples were subjected to electrophoresis using MegaBACEtrade mark 500 (Amersham Biosciences, Germany) and sequencing traces were analysed using the Mutation Surveyor v2.61 (Softgenetics Inc., USA) programme.
###end p 36
###begin p 37
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
We are grateful to Dr Nancy Tan for leading on earlier work on BRCA1 and BRCA2 in this cohort and to Dr Eswary Thirthagiri for comments on the manuscript.
###end p 37
###begin title 38
References
###end title 38
###begin article-title 39
GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide.
###end article-title 39
###begin article-title 40
International Variation.
###end article-title 40
###begin article-title 41
Second Report of the National Cancer Registry. Cancer Incidence in Malaysia 2003.
###end article-title 41
###begin article-title 42
###xml 15 20 <span type="species:ncbi:9606">Women</span>
"Westernizing" Women's Risk? Breast cancer in lower-income countries.
###end article-title 42
###begin article-title 43
The genetic attributable risk of breast and ovarian cancer.
###end article-title 43
###begin article-title 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 54 59 <span type="species:ncbi:9606">women</span>
BRCA1 mutations in a population-based sample of young women with breast cancer.
###end article-title 44
###begin article-title 45
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 50 55 <span type="species:ncbi:9606">women</span>
Germ-line BRCA1 mutation in Jewish and non-Jewish women with early-onset breast cancer.
###end article-title 45
###begin article-title 46
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
###end article-title 46
###begin article-title 47
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
###end article-title 47
###begin article-title 48
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Identification of the breast cancer susceptibility gene BRCA2.
###end article-title 48
###begin article-title 49
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
Risks of cancer in BRCA1 mutation carriers. Breast Cancer Linkage Consortium.
###end article-title 49
###begin article-title 50
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Population based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
###end article-title 50
###begin article-title 51
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.
###end article-title 51
###begin article-title 52
Genomic medicine: breast and ovarian cancer.
###end article-title 52
###begin article-title 53
Modifiers of risk of hereditary breast cancer.
###end article-title 53
###begin article-title 54
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Hereditary breast and ovarian cancer in Asia: Genetic Epidemiology of BRCA1 and BRCA2.
###end article-title 54
###begin article-title 55
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Mutations in the BRCA1 gene in Japanese breast cancer patients.
###end article-title 55
###begin article-title 56
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer.
###end article-title 56
###begin article-title 57
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 43 48 <span type="species:ncbi:9606">women</span>
Novel germline BRCA1 mutations detected in women in Singapore who developed breast carcinoma before the age of 36 years.
###end article-title 57
###begin article-title 58
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives.
###end article-title 58
###begin article-title 59
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
###end article-title 59
###begin article-title 60
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
BRCA1 and BRCA2 in Indian breast cancer patients.
###end article-title 60
###begin article-title 61
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.
###end article-title 61
###begin article-title 62
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Mutation analysis of the BRCA1 gene in Malaysian breast cancer patients.
###end article-title 62
###begin article-title 63
Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002.
###end article-title 63
###begin article-title 64
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 29 34 <span type="species:ncbi:9606">women</span>
BRCA1 and BRCA2 mutations in women from Shanghai China.
###end article-title 64
###begin article-title 65
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Analysis of missense variation in human BRCA1 in the context of inter-specific sequence variation.
###end article-title 65
###begin article-title 66
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.
###end article-title 66
###begin article-title 67
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients.
###end article-title 67
###begin article-title 68
SIFT: predicting amino acid changes that affect protein function.
###end article-title 68
###begin p 69
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 69
###begin p 70
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was funded by the supporters of Cancer Research Initiatives Foundation, a non-profit research organisation established to conduct research on cancers as they occur in Malaysia, and through a grant from the Malaysian Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 70

